We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Noul Showcases AI-Driven Blood and Cancer Diagnostic Platform

By LabMedica International staff writers
Posted on 15 Nov 2023
Print article
Image: The miLab AI-based electro-dynamic blood diagnostic platform (Photo courtesy of Noul)
Image: The miLab AI-based electro-dynamic blood diagnostic platform (Photo courtesy of Noul)

Noul Co., Ltd. (Gyeonggi-do, Korea) is showcasing its AI-driven blood and cancer diagnostic platform, miLab, alongside its new product for automatically staining and analyzing cervical cells, at MEDICA 2023.

Based on its AI-based electro-dynamic blood diagnostic platform miLab, Noul offers various solutions. miLab MAL performs diagnostic processes from staining, and digital imaging to AI analysis with ~5µL of blood from fingertips and diagnoses malaria infection within 15 minutes by analyzing up to 300,000 red blood cells. miLab BCM performs diagnostic processes from staining, and digital imaging to AI analysis with ~5µL of blood obtained through fingertips or from veins. It provides high-definition digital images of white blood cells, red blood cells, and platelets, as well as pre-classification. miLab CER performs diagnostic processes from staining, and digital imaging to AI analysis on cervical cells and analyzes each cell’s characteristics to provide analysis results grouped into stages.

Noul’s new product unveiled at MEDICA 2023, ‘miLab Cartridge CER’ is designed for automatically staining and analyzing cervical cells. It stains cervico-vaginal samples smeared manually or by LBC using the Papanicolaou staining combined with NGSI, a solid-based staining technology developed by Noul. When used with miLab, Noul’s AI-based diagnostic platform, it provides staining, imaging, and cell analysis results that assist user’s decision-making. Through the launch of its new product, the company aims to contribute to the early diagnosis of cervical cancer, the fourth largest cancer in the world for women.

Related Links:
Noul Co., Ltd. 

New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Drug Detection Platform
ABSOLUDY Drug Detection Platform
New
Preterm Delivery Test
PREMAQUICK

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The researchers used state-of the-art equipment for isotope ratio mass spectrometry (Photo courtesy of The University of Melbourne)

New Blood Test to Detect Alzheimer’s Disease Before Clinical Symptoms Develop

Alzheimer’s disease (AD) is the most common form of dementia, accounting for 60-70% of cases worldwide, totaling over 33 million, according to the World Health Organization. As the global population ages,... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The ChatGPT-like AI model can diagnose cancer, guide treatment choice, predict survival across multiple cancer types (Photo courtesy of 123RF)

AI Tool Diagnoses Cancer, Guides Treatment and Predicts Survival Across Multiple Cancer Types

Current artificial intelligence (AI) models are typically specialized, designed for specific tasks like detecting cancer or predicting tumor genetics, and are limited to a few cancer types.... Read more

Industry

view channel
Image: Roche has expanded its digital pathology open environment with more than 20 AI algorithms (Photo courtesy of Roche)

Roche Expands Digital Pathology Open Environment with Integration of Advanced AI Algorithms from New Collaborators

Roche (Basel, Switzerland) has expanded its digital pathology open environment by integrating over 20 advanced artificial intelligence (AI) algorithms from eight new collaborators. These strategic collaborations... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.